Shane O’Grady

1.6k total citations · 1 hit paper
19 papers, 996 citations indexed

About

Shane O’Grady is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Shane O’Grady has authored 19 papers receiving a total of 996 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Molecular Biology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Shane O’Grady's work include Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (2 papers) and Pneumonia and Respiratory Infections (2 papers). Shane O’Grady is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (2 papers) and Pneumonia and Respiratory Infections (2 papers). Shane O’Grady collaborates with scholars based in Ireland, United States and United Kingdom. Shane O’Grady's co-authors include John Crown, Michael J. Duffy, Maria P. Morgan, Minhong Tang, Naoise C. Synnott, Sinéad Cuffe, Martin P. Barr, Stephen P. Finn, Derek J. Richard and Kenneth J. O’Byrne and has published in prestigious journals such as Cancer Research, Scientific Reports and Seminars in Cancer Biology.

In The Last Decade

Shane O’Grady

18 papers receiving 987 citations

Hit Papers

MYC as a target for cancer treatment 2021 2026 2022 2024 2021 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. MYC as a target for cancer treatment
    2021 296 citations Michael J. Duffy, Shane O’Grady et al. Cancer Treatment Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shane O’Grady Ireland 12 611 365 222 125 81 19 996
Yiyu Dong United States 16 731 1.2× 328 0.9× 203 0.9× 220 1.8× 71 0.9× 26 1.2k
Alex J. Eustace Ireland 20 688 1.1× 429 1.2× 347 1.6× 163 1.3× 79 1.0× 52 1.2k
Hui Xing China 22 768 1.3× 343 0.9× 387 1.7× 100 0.8× 122 1.5× 54 1.2k
Mingsheng Zhang China 13 584 1.0× 392 1.1× 240 1.1× 186 1.5× 78 1.0× 29 1.1k
Fengfeng Cai China 19 602 1.0× 289 0.8× 359 1.6× 92 0.7× 84 1.0× 44 1.1k
Min Kyung Ju South Korea 12 691 1.1× 365 1.0× 469 2.1× 136 1.1× 100 1.2× 16 1.1k
Sarah Sarkar United States 12 486 0.8× 356 1.0× 268 1.2× 137 1.1× 69 0.9× 13 980
Victoria J. Spanswick United Kingdom 21 914 1.5× 462 1.3× 258 1.2× 94 0.8× 58 0.7× 39 1.3k
Charles Pottier Belgium 14 539 0.9× 362 1.0× 299 1.3× 218 1.7× 155 1.9× 15 1.0k

Countries citing papers authored by Shane O’Grady

Since Specialization
Citations

This map shows the geographic impact of Shane O’Grady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shane O’Grady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shane O’Grady more than expected).

Fields of papers citing papers by Shane O’Grady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shane O’Grady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shane O’Grady. The network helps show where Shane O’Grady may publish in the future.

Co-authorship network of co-authors of Shane O’Grady

This figure shows the co-authorship network connecting the top 25 collaborators of Shane O’Grady. A scholar is included among the top collaborators of Shane O’Grady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shane O’Grady. Shane O’Grady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
O’Grady, Shane, Jessica C. Ralston, Eadaoin McKiernan, et al.. (2025). Invisible spectrum: a model for minority community public engagement in cancer research. Research Involvement and Engagement. 11(1). 53–53.
2.
O’Grady, Shane, John Crown, & Michael J. Duffy. (2022). Statins inhibit proliferation and induce apoptosis in triple-negative breast cancer cells. Medical Oncology. 39(10). 142–142. 24 indexed citations
3.
Tang, Minhong, Shane O’Grady, John Crown, & Michael J. Duffy. (2022). MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975. Breast Cancer Research and Treatment. 195(2). 105–115. 25 indexed citations
4.
Duffy, Michael J., et al.. (2022). Targeting Mutant p53 for Cancer Treatment: Moving Closer to Clinical Use?. Cancers. 14(18). 4499–4499. 30 indexed citations
5.
O’Grady, Shane, Mary M Tecklenburg, Keith D. Rogers, et al.. (2021). A time-course Raman spectroscopic analysis of spontaneous in vitro microcalcifications in a breast cancer cell line. Laboratory Investigation. 101(9). 1267–1280. 8 indexed citations
6.
Duffy, Michael J., Shane O’Grady, Minhong Tang, & John Crown. (2021). MYC as a target for cancer treatment. Cancer Treatment Reviews. 94. 102154–102154. 296 indexed citations breakdown →
7.
Duffy, Michael J., Naoise C. Synnott, Shane O’Grady, & John Crown. (2020). Targeting p53 for the treatment of cancer. Seminars in Cancer Biology. 79. 58–67. 244 indexed citations
8.
Kavanagh, Emma, Shane O’Grady, Alex J. Eustace, et al.. (2020). The novel low molecular weight MYC antagonist MYCMI-6 inhibits proliferation and induces apoptosis in breast cancer cells. Investigational New Drugs. 39(2). 587–594. 21 indexed citations
9.
O’Grady, Shane, John Crown, & Michael J. Duffy. (2020). Abstract 1775: Anti-tumor effects of statins in triple-negative breast cancer: Apoptosis, chemosensitization and degradation of mutant-p53. Cancer Research. 80(16_Supplement). 1775–1775. 1 indexed citations
10.
O’Grady, Shane & Maria P. Morgan. (2019). Calcium transport and signalling in breast cancer: Functional and prognostic significance. Seminars in Cancer Biology. 72. 19–26. 26 indexed citations
11.
12.
O’Grady, Shane & Maria P. Morgan. (2018). Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1869(2). 310–320. 105 indexed citations
13.
Kia, Agnieszka Foltyn-Arfa, Shane O’Grady, Maria P. Morgan, et al.. (2016). Polymeric prodrug combination to exploit the therapeutic potential of antimicrobial peptides against cancer cells. Organic & Biomolecular Chemistry. 14(39). 9278–9286. 30 indexed citations
14.
O’Grady, Shane, Stephen P. Finn, Sinéad Cuffe, et al.. (2014). The role of DNA repair pathways in cisplatin resistant lung cancer. Cancer Treatment Reviews. 40(10). 1161–1170. 121 indexed citations
15.
Caprau, Diana, Michelle E. Schober, Shane O’Grady, et al.. (2012). Altered expression and chromatin structure of the hippocampal IGF1r gene is associated with impaired hippocampal function in the adult IUGR male rat. Journal of Developmental Origins of Health and Disease. 3(2). 83–91. 13 indexed citations
16.
Haley, Shannon, Shane O’Grady, Beth M. Bowman, et al.. (2011). Mechanical-tactile stimulation (MTS) intervention in a neonatal stress model improves long-term outcomes on bone.. PubMed. 11(3). 234–42. 5 indexed citations
17.
Caprau, Diana, Shane O’Grady, Christopher W. Callaway, et al.. (2007). 1A-4 IUGR alters IGF1 receptor gene expression, DNA methylation and histones acetylation in the brain. Early Human Development. 83. S47–S47. 2 indexed citations
18.
O’Grady, Shane, et al.. (2002). Utility of Zanamivir for Chemoprophylaxis of Concomitant Influenza A and B in a Complex Continuing Care Population. Infection Control and Hospital Epidemiology. 23(10). 604–608. 8 indexed citations
19.
O’Grady, Shane, et al.. (2001). Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing-care population.. PubMed. 27(3). 21–4. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yiyu Dong Breakdown of academic impact, for papers by Alex J. Eustace Breakdown of academic impact, for papers by Hui Xing Breakdown of academic impact, for papers by Mingsheng Zhang Breakdown of academic impact, for papers by Fengfeng Cai Breakdown of academic impact, for papers by Min Kyung Ju Breakdown of academic impact, for papers by Sarah Sarkar Breakdown of academic impact, for papers by Victoria J. Spanswick Breakdown of academic impact, for papers by Charles Pottier
Rankless by CCL
2026